Regeneron hit by 'safety signal' for COVID-19 cocktail as data board tells pharma to stop enrolling sicker patients

Regeneron hit by 'safety signal' for COVID-19 cocktail as data board tells pharma to stop enrolling sicker patients

Submitted by admin on October 30, 2020 - 10:14am
Source: 
Fierce Biotech
News Tags: 
Regeneron
antibodies
FDA
clinical trials
COVID-19
IDMC
Headline: 
Regeneron hit by 'safety signal' for COVID-19 cocktail as data board tells pharma to stop enrolling sicker patients
snippet: 

The saga of COVID-19 antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump and touted as a cure has been hit by safety worries as it continues to push for an FDA emergency authorization.

Do Not Allow Advertisers to Use My Personal information